metoclopramide has been researched along with Bruxism, Nocturnal in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "They differed from the usual features of nocturnal bruxism in hypoperfusion of the left frontal lobe, a poor response to l-dopa or bromocriptine therapy and a favourable response to metoclopramide." | 1.33 | A proposed mechanism for diurnal/nocturnal bruxism: hypersensitivity of presynaptic dopamine receptors in the frontal lobe. ( Chen, WH; Liu, JS; Lu, YC; Lui, CC, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WH | 1 |
| Lu, YC | 1 |
| Lui, CC | 1 |
| Liu, JS | 1 |
1 other study available for metoclopramide and Bruxism, Nocturnal
| Article | Year |
|---|---|
A proposed mechanism for diurnal/nocturnal bruxism: hypersensitivity of presynaptic dopamine receptors in the frontal lobe.
Topics: Aged; Bromocriptine; Bruxism; Dopamine Agents; Female; Frontal Lobe; Humans; Levodopa; Male; Metoclo | 2005 |